共 46 条
- [45] First-in-human phase 1/2 trial of intravenous FBX-101 following hematopoietic stem cell transplantation increases GALC activity, supports brain development, and improves motor function in patients with infantile Krabbe disease: RESKUE clinical trial MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 39 - 39